URINARY SE-CADHERIN AND PLASMA CYSTATIN C AS NOVEL BIOMARKERS OF DIABETIC NEPHROPATHY

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Zagazig university medical journal

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21608/ZUMJ.2014.4369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes.

  2013cited by this paper
• Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study

  2013cited by this paper
• Urinary biomarkers in obstructive nephropathy.

  2012cited by this paper
• Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients

  2012cited by this paper
• Spot Urine Albumin to Creatinine Ratio and Serum Cystatin C are Effective for Detection of Diabetic Nephropathy in Childhood Diabetic Patients

  2012cited by this paper
• Role of Cystatin-C in assessing the cardiovascular risk among overweight and obese individuals

  2012cited by this paper
• Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease.

  2012cited by this paper
• Estimation of glomerular filtration rate using serum cystatin C in overweight and obese subjects.

  2011cited by this paper
• Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study

  2011cited by this paper
• [Molecular mechanism of proteinuria caused progression of chronic renal disease].

  2010cited by this paper
• Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size.

  2010cited by this paper
• Cubilin is essential for albumin reabsorption in the renal proximal tubule.

  2010cited by this paper
• PKC-delta promotes renal tubular cell apoptosis associated with proteinuria.

  2010cited by this paper
• Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria.

  2010cited by this paper
• Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.

  2010cited by this paper
• Proteomic Identification of Human Urinary Biomarkers in Diabetes Mellitus Type 2

  2010cited by this paper
• Prevalence of microalbuminuria with relation to glycemic control in type-2 diabetic patients in Karachi.

  2009cited by this paper
• Is Serum Cystatin C an Accurate Endogenous Marker of Glomerular Filteration Rate for Detection of Early Renal Impairment in Patients with Type 2 Diabetes Mellitus?

  2009cited by this paper
• Identification of urinary soluble E‐cadherin as a novel biomarker for diabetic nephropathy

  2009cited by this paper
• Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.

  2009cited by this paper
• Direct All-Cause Health Care Costs Associated With Chronic Kidney Disease in Patients With Diabetes and Hypertension: A Managed Care Perspective

  2009cited by this paper
• Normal reference levels of serum cystatin C in Saudi adults.

  2008cited by this paper
• Overweight, obesity, and elevated serum cystatin C levels in adults in the United States.

  2008cited by this paper
• The death ligand TRAIL in diabetic nephropathy.

  2008cited by this paper
• Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.

  2008cited by this paper
• Megalin-mediated endocytosis of cystatin C in proximal tubule cells.

  2007cited by this paper
• Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.

  2007cited by this paper
• A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.

  2007cited by this paper
• Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients.

  2007cited by this paper
• Adult cystatin C reference intervals determined by nephelometric immunoassay.

  2007cited by this paper
• Cystatin C reference values and aging.

  2006cited by this paper
• Update in Diabetic Nephropathy

  2005cited by this paper
• Measurement of kidney function.

  2005cited by this paper
• Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.

  2005cited by this paper
• Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.

  2005cited by this paper
• Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.

  2005cited by this paper
• Cystatin C as a marker of GFR--history, indications, and future research.

  2005cited by this paper
• Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease.

  2005cited by this paper
• Early nephropathy in type 1 diabetes: A new perspective on who will and who will not progress

  2005cited by this paper
• Increased cystatin C concentration in urine of nephrotic children

  2004cited by this paper
• Renal structure in type 2 diabetes

  2004cited by this paper
• Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.

  2004cited by this paper
• Epithelial-mesenchymal transition and its implications for fibrosis.

  2003cited by this paper
• High prevalence of immuno-unreactive intact albumin in urine of diabetic patients.

  2003cited by this paper
• Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.

  2002cited by this paper
• Determination of Serum Cystatin C: Biological Variation and Reference Values

  2001cited by this paper
• Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

  2001cited by this paper
• Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

  2001cited by this paper
• Structure and Functions of Classical Cadherins

  2001cited by this paper
• Reference intervals for plasma cystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II System, and correlation with creatinine.

  2001cited by this paper
• Cleavage and Shedding of E-cadherin after Induction of Apoptosis*

  2001cited by this paper
• Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.

  2001cited by this paper
• Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance

  2000cited by this paper
• Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia.

  2000cited by this paper
• Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress.

  2000cited by this paper
• Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation.

  1999cited by this paper
• Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy.

  1999cited by this paper
• Differential expression and function of cadherin-6 during renal epithelium development.

  1998cited by this paper
• Mitogen-Activated Protein Kinase Cascade Is Activated in Glomeruli of Diabetic Rats and Glomerular Mesangial Cells Cultured Under High Glucose Conditions

  1997cited by this paper
• Ischemia causes rapidly progressive nephropathy in the diabetic rat.

  1997cited by this paper
• Cystatin C measurement and its practical use in patients with various renal diseases.

  1997cited by this paper
• Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies.

  1994cited by this paper
• Immunoassay of low concentrations of albumin in urine by latex particle counting.

  1988cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• COMMENTARY The cadherin superfamily: diversity in form and function

  year unknowncited by this paper
• Clinical Medicine Insights: Endocrinology and Diabetes O R I G I N a L R E S E a R C H Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus

  year unknowncited by this paper

• Urinary immunoglobulin G versus microalbuminuria as an indicator of diabetic nephropathy in type 2 diabetic patients

  2018cites this paper
• Urinary Cadherin E a Marker for Early Detection of Diabetic Urinary Cadherin E a Marker for Early Detection of Diabetic Nephropathy Nephropathy

  year unknowncites this paper